Biphenabid (Probucol): a new hypocholesterolemic agent.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000924:Anticholesteremic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood / Q000188:drug therapy*; D007677:Kidney Function Tests; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D010636:Phenols / Q000008:administration & dosage / Q000627:therapeutic use*; D010919:Placebos; D013440:Sulfides / Q000008:administration & dosage / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood
D000924:Anticholesteremic Agents; D010636:Phenols; D010919:Placebos; D013440:Sulfides; D014280:Triglycerides; D002784:Cholesterol